| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Obstetrics and Gynecology & Physiology, University of Alberta, Edmonton, Alberta, Canada
2 Universidad Industrial de Santander, Bucaramanga, Santander, Colombia; Fundacion Cardiovascular del Oriente, Bucaramanga, Santander, Colombia
* To whom correspondence should be addressed. E-mail: sandra.davidge{at}ualberta.ca.
Abstract-Angiotensin II (AII) has been etiologically linked to vascular disease; however, its role in the alterations of endothelial function that occur in vascular disorders is not completely understood. Matrix metalloproteinases and proinflammatory cytokines have been involved in the pathological remodeling of blood vessels that occurs in vascular disease. In this study we evaluated the effects of AII on TNF
and MMP-2 production in endothelial cells. Human umbilical vein endothelial cells were stimulated with AII (0.1 to 10 mM) for 24 hours, in the presence or absence of antagonists of AT1R and AT2R, and the production and release of TNFa and MMP-2 were assessed. AII increased TNF mRNA, protein expression, and the release of bioactive TNF. Moreover, AII induced MMP-2 release and reduced the secretion of TIMP-2 from endothelial cells. To elucidate whether endogenous TNF could mediate the effects of AII on MMP-2 release, cells were pre-treated with neutralizing antibodies anti-TNF or pentoxifylline (a selective inhibitor of TNF synthesis). TNF inhibition prevented the secretion of MMP-2 induced by AII. Furthermore, AT1R antagonism with candesartan prevented the formation of MMP-2 and TNF, and the reduction of TIMP-2 induced by AII. These results indicate that AII via AT1R modulates the secretion of TNF and MMP-2 from endothelial cells, and that TNF mediates the effects of AII on MMP-2 release.
This article has been cited by other articles:
|
|
 |
|
  Y. Zhang, J. C. Naggar, C. M. Welzig, D. Beasley, K. S. Moulton, H.-J. Park, and J. B. Galper Simvastatin Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice: Possible Role of ERK Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1764 - 1771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-M. Kang, Y. Ma, J.-P. Zheng, C. Elks, S. Sriramula, Z.-M. Yang, and J. Francis Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension Cardiovasc Res, June 1, 2009; 82(3): 503 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E. Striker, F. Praddaude, O. Alcazar, S. W. Cousins, and M. E. Marin-Castano Regulation of angiotensin II receptors and extracellular matrix turnover in human retinal pigment epithelium: role of angiotensin II Am J Physiol Cell Physiol, December 1, 2008; 295(6): C1633 - C1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sriramula, M. Haque, D. S.A. Majid, and J. Francis Involvement of Tumor Necrosis Factor-{alpha} in Angiotensin II-Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy Hypertension, May 1, 2008; 51(5): 1345 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Flamant, S. Placier, C. Dubroca, B. Esposito, I. Lopes, C. Chatziantoniou, A. Tedgui, J.-C. Dussaule, and S. Lehoux Role of Matrix Metalloproteinases in Early Hypertensive Vascular Remodeling Hypertension, July 1, 2007; 50(1): 212 - 218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Mehta and K. K. Griendling Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system Am J Physiol Cell Physiol, January 1, 2007; 292(1): C82 - C97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Alfonso-Jaume, M. R. Bergman, R. Mahimkar, S. Cheng, Z. Q. Jin, J. S. Karliner, and D. H. Lovett Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1838 - H1846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Y. Han, Y. H. Jee, K. H. Han, Y. S. Kang, H. K. Kim, J. Y. Han, Y. S. Kim, and D. R. Cha An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2406 - 2416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge Tumor Necrosis Factor-{alpha} and Vascular Angiotensin II in Estrogen-Deficient Rats Hypertension, September 1, 2006; 48(3): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ben-Yosef, A. Miller, S. Shapiro, and N. Lahat Hypoxia of endothelial cells leads to MMP-2-dependent survival and death Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1321 - C1331. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
